Published in Photochem Photobiol Sci on October 15, 2009
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling. J Biophotonics (2010) 1.71
Influences of tissue absorption and scattering on diffuse correlation spectroscopy blood flow measurements. Biomed Opt Express (2011) 1.52
Direct measurement of tissue blood flow and metabolism with diffuse optics. Philos Trans A Math Phys Eng Sci (2011) 1.42
Tumor blood flow differs between mouse strains: consequences for vasoresponse to photodynamic therapy. PLoS One (2012) 1.18
Monitoring blood flow responses during topical ALA-PDT. Biomed Opt Express (2010) 1.06
Near-infrared diffuse correlation spectroscopy in cancer diagnosis and therapy monitoring. J Biomed Opt (2012) 1.05
A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging. Lasers Surg Med (2013) 1.02
Preoperative mapping of nonmelanoma skin cancer using spatial frequency domain and ultrasound imaging. Acad Radiol (2014) 1.01
Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate. Radiat Res (2010) 0.95
Tumor vascular microenvironment determines responsiveness to photodynamic therapy. Cancer Res (2012) 0.88
Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study. J Biomed Opt (2016) 0.86
Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling. J Biophotonics (2016) 0.82
Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma. Photodiagnosis Photodyn Ther (2011) 0.79
Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities. Pharmaceuticals (Basel) (2010) 0.79
Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response. Isr J Chem (2012) 0.78
Scanning, non-contact, hybrid broadband diffuse optical spectroscopy and diffuse correlation spectroscopy system. Biomed Opt Express (2016) 0.77
Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen. Bioorg Med Chem (2016) 0.76
Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity. Int J Mol Sci (2016) 0.75
Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy. J Biomed Opt (2017) 0.75
Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy. Sci Rep (2016) 0.75
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res (2005) 2.33
A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. Med Phys (2007) 2.03
Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer (2009) 2.00
Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res (1991) 1.97
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res (2004) 1.80
Structural adaptation and heterogeneity of normal and tumor microvascular networks. PLoS Comput Biol (2009) 1.62
Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer (1998) 1.46
Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome. Cancer Res (2004) 1.39
Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol (2000) 1.34
Fluence rate as a modulator of PDT mechanisms. Lasers Surg Med (2006) 1.24
Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol (2002) 1.23
Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt (2005) 1.22
Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res (2008) 1.11
The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem Photobiol (1998) 1.10
Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin Cancer Res (2008) 1.07
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clin Cancer Res (2005) 1.05
Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol (2004) 1.04
Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys (2005) 1.03
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res (2004) 1.03
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res (2002) 0.98
Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg (2006) 0.97
In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res (1999) 0.97
Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res (2002) 0.97
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]. Cancer Res (2000) 0.96
Effect of photosensitizer dose on fluence rate responses to photodynamic therapy. Photochem Photobiol (2007) 0.93
The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry. Photochem Photobiol Sci (2007) 0.92
Local physiological changes during photodynamic therapy. Lasers Surg Med (2006) 0.88
Optical properties of adenocarcinoma and squamous cell carcinoma of the gastroesophageal junction. J Biomed Opt (2007) 0.88
Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature. Ophthalmic Res (2009) 0.85
Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol (2005) 0.84
Quantitative spatial analysis of hypoxia and vascular perfusion in tumor sections. Adv Exp Med Biol (2003) 0.84
Carbogen breathing significantly enhances the penetration of red light in murine tumours in vivo. Phys Med Biol (2004) 0.81
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express (2007) 2.84
Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys (2005) 2.76
Diffuse optical tomography of cerebral blood flow, oxygenation, and metabolism in rat during focal ischemia. J Cereb Blood Flow Metab (2003) 2.70
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49
Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med (2006) 2.36
Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res (2005) 2.33
Noninvasive measurement of cerebral blood flow and blood oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-injured adults. Neurocrit Care (2010) 2.26
Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend (2009) 2.15
Diffuse optical measurement of blood flow, blood oxygenation, and metabolism in a human brain during sensorimotor cortex activation. Opt Lett (2004) 2.12
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt (2007) 2.01
Diffuse optical tomography with spectral constraints and wavelength optimization. Appl Opt (2005) 2.00
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology (2006) 1.93
Validation of diffuse correlation spectroscopy for muscle blood flow with concurrent arterial spin labeled perfusion MRI. Opt Express (2007) 1.93
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90
Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the Therapy Physics Committee of the AAPM. Med Phys (2008) 1.89
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer. Lasers Surg Med (2002) 1.86
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
A method for determination of the absorption and scattering properties interstitially in turbid media. Phys Med Biol (2005) 1.82
Diffuse optical monitoring of hemodynamic changes in piglet brain with closed head injury. J Biomed Opt (2009) 1.82
Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J Biomed Opt (2009) 1.82
A review of in-vivo optical properties of human tissues and its impact on PDT. J Biophotonics (2011) 1.78
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ (2010) 1.77
Optical measurement of cerebral hemodynamics and oxygen metabolism in neonates with congenital heart defects. J Biomed Opt (2010) 1.75
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling. J Biophotonics (2010) 1.71
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2007) 1.69
Uniqueness and wavelength optimization in continuous-wave multispectral diffuse optical tomography. Opt Lett (2003) 1.67
Diffuse optical measurement of blood flow in breast tumors. Opt Lett (2005) 1.65
Spatiotemporal quantification of cerebral blood flow during functional activation in rat somatosensory cortex using laser-speckle flowmetry. J Cereb Blood Flow Metab (2004) 1.64
Time-dependent blood flow and oxygenation in human skeletal muscles measured with noninvasive near-infrared diffuse optical spectroscopies. J Biomed Opt (2005) 1.63
Diffuse optical correlation tomography of cerebral blood flow during cortical spreading depression in rat brain. Opt Express (2006) 1.62
Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke (2014) 1.62
Applying a behavioral economic framework to understanding adolescent smoking. Psychol Addict Behav (2004) 1.61
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59
Cerebral hemodynamics in preterm infants during positional intervention measured with diffuse correlation spectroscopy and transcranial Doppler ultrasound. Opt Express (2009) 1.58
Influences of tissue absorption and scattering on diffuse correlation spectroscopy blood flow measurements. Biomed Opt Express (2011) 1.52
Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study. J Biomed Opt (2007) 1.51
Energy dependence of commercially available diode detectors for in-vivo dosimetry. Med Phys (2007) 1.50
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change. Pediatrics (2011) 1.48
Portable optical tissue flow oximeter based on diffuse correlation spectroscopy. Opt Lett (2009) 1.48
Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express (2009) 1.46
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
Analytic function for predicting light fluence rate of circular fields on a semi-infinite turbid medium. Opt Express (2016) 1.43
Direct measurement of tissue blood flow and metabolism with diffuse optics. Philos Trans A Math Phys Eng Sci (2011) 1.42
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry (2010) 1.38
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One (2009) 1.37
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med (2006) 1.34
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol (2003) 1.32
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res (2008) 1.26
Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol (2005) 1.25
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res (2004) 1.24
In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. Phys Med Biol (2002) 1.23
Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med (2005) 1.23
Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt (2005) 1.22
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol (2006) 1.21
Simultaneous measurement of deep tissue blood flow and oxygenation using noncontact diffuse correlation spectroscopy flow-oximeter. Sci Rep (2013) 1.20
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res (2006) 1.19
Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. Med Phys (2005) 1.18
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry (2006) 1.18
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem Photobiol (2007) 1.17
Validation of diffuse correlation spectroscopic measurement of cerebral blood flow using phase-encoded velocity mapping magnetic resonance imaging. J Biomed Opt (2012) 1.14
An algorithm for learning maximum entropy probability models of disease risk that efficiently searches and sparingly encodes multilocus genomic interactions. Bioinformatics (2009) 1.14
Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics (2002) 1.13
Noninvasive optical evaluation of spontaneous low frequency oscillations in cerebral hemodynamics. Neuroimage (2012) 1.13
Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol (2011) 1.12
Noncontact diffuse correlation spectroscopy for noninvasive deep tissue blood flow measurement. J Biomed Opt (2012) 1.12
Diffuse optical monitoring of repeated cerebral ischemia in mice. Opt Express (2011) 1.12
Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry (2006) 1.12
The effects of healthy aging on cerebral hemodynamic responses to posture change. Physiol Meas (2010) 1.12
Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet (2008) 1.12
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy. Phys Med Biol (2008) 1.10
Cerebral monitoring during carotid endarterectomy using near-infrared diffuse optical spectroscopies and electroencephalogram. Phys Med Biol (2011) 1.08
Proximity induced high-temperature magnetic order in topological insulator--ferrimagnetic insulator heterostructure. Nano Lett (2014) 1.08
Compressed sensing in diffuse optical tomography. Opt Express (2010) 1.08
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. J Subst Abuse Treat (2007) 1.08
Effects of muscle fiber motion on diffuse correlation spectroscopy blood flow measurements during exercise. Biomed Opt Express (2010) 1.07
Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol. BMJ Open (2014) 1.07
Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies. Opt Express (2007) 1.05